VC Fund Dossiers

360 Capital is one of Europe's most successful old-school VC shops that actually delivers results—their Preligens exit to Safran for €220M in 2024 and backing Exotec to become France's first industrial unicorn proves they know how to pick winners and get liquidity. Founded in 1997, they've survived multiple cycles and have the conviction to back deep tech when others chase software. Fausto Boni is a genuine operator with McKinsey pedigree who sits on boards and gets his hands dirty. The dual Paris-Milan setup gives them unique access to Southern European talent that coastal VCs miss. Their 71% seed to Series A conversion rate (92% including exits) is exceptional. Watch for their climate tech focus with the new €140M 360 LIFE II fund—they're betting big on energy transition when others just talk about it.

3VC is the disciplined European operator you want when the market gets frothy. While other funds were throwing money at inflated rounds in 2021, they stayed selective with their 3-4 deals per year strategy. This 'quality over quantity' approach paid off with 3 unicorns from just 12 Fund I companies - that's a 25% unicorn rate that would make Sequoia jealous. The team genuinely gets product-market fit (Eva's IoT background shows) and isn't afraid to get their hands dirty - they literally structured Gamee's acquisition by Animoca Brands during tough times. The downside? They're picky as hell and take forever to decide, plus their DACH/CEE focus means they might miss broader European trends.

This is the Rocket Internet alumni club rebranded for the deep tech era. The founding team - Kudlich from Rocket Internet/GFC, Ensthaler from GFC, and Leibert from Mesosphere - brings serious operational DNA and a track record of scaling tech companies. They've raised $1.3B across two funds since 2020, with Fund II closing at $400M. The good: they actually understand enterprise software and have skin in the game as former founders. They're betting big on MLOps and open source commercialization with investments in QuestDB, Iterative.ai, and ActivLoop. The watch-out: they have 3 unicorns (Razor Group, ClickUp, PandaDoc) but also some portfolio company exits that suggest they're not afraid to cut losses. They move fast and have strong conviction, but expect them to be hands-on - these aren't passive check-writers.

These guys are the anti-European VC stereotype—they actually write first checks into wild moonshots that European funds would pass on for being 'too early.' Both Oculus and Magic Pony were their first institutional money, which tells you everything about their conviction. They promise blunt feedback within 5 working days even on rejections, which founders love because you're not left hanging. The geopolitical 'free-world resilience' framing feels a bit performative, but their portfolio backs it up—they're genuinely betting on technologies that matter for Western competitiveness. They don't take board seats and see their value in the first 6-12 months helping you prep for the next round, so they're not going to micromanage you to death.

Act met Barry Napier "over a decade ago" and made "the largest seed investment we possibly could" - this is a fund that bets big early and doubles down on winners. They explicitly say "We have never been the loudest venture firm" and "don't want to add to the noise of VCs making it about them." Strong exit track record including SilverCloud Health (acquired by Amwell), Decawave (acquired by Qorvo), and 34 total portfolio exits. Their strategy is clear: "find the best company builders at the earliest stages and continue to back them again and again." This isn't a spray-and-pray fund - they're conviction-driven, founder-focused, and have the dry powder (€140M Fund VI) to support you through multiple rounds.

Aglae is essentially Bernard Arnault's tech investment arm masquerading as a standalone VC - which is both their superpower and their Achilles heel. They have stupid money (LVMH backing means they can write big checks without blinking), phenomenal brand access through the luxury ecosystem, and a track record that includes some absolute bangers. But here's the catch: they're not really building a venture brand, they're executing family office investment strategy. The team is solid but small, and while Antoine brings decent deal flow, this isn't Sequoia-level pattern recognition. If you need growth capital and can benefit from luxury/premium brand connections, they're golden. If you want hands-on operational support or deep sector expertise, look elsewhere.

Nathan Benaich is the rare VC who actually knows what he's talking about technically - his PhD in cancer biology and decade of State of AI Reports mean he spots trends before other VCs even know they exist. As Europe's largest solo GP fund with $232M, he can move fast with single decision-maker speed and write meaningful checks. The guy is obsessed with "AI-first" companies where removing the AI kills the product entirely, which filters out a lot of AI-washing. He's particularly interested in European defense capabilities and wants founders with maniacal focus combined with humility. The downside? Europe still has a thinner pipeline of globally scalable AI companies compared to North America, so you're betting on that gap closing. But if you're building something truly AI-native in biotech, robotics, or defense, few investors will understand your technology better or move faster.

Aldea gets it - they're not trying to be heroes, they're smart money that understands the fund-of-funds game. Portfolio managers praise them for being "more than an investor - a true partner" who shows "real alignment" and "patience" with long deeptech timelines. They're playing the data game smartly, collecting intelligence on 1000+ companies to make better decisions while sharing anonymized insights with the ecosystem. The team has solid pedigree from established European funds, not Silicon Valley wannabes. They're also a certified B-Corp with a 95.3 impact score (median is 50.9), so they actually walk the sustainability talk. The concentration strategy in Fund II shows they're learning and getting pickier, which is what you want to see.

Alliance is the rare Nordic VC that actually walks the walk on 'founder-friendly' instead of just talking about it. From your very first meeting, you're speaking directly with a partner — no junior associates wasting your time. Every partner has equal voting power and they make decisions by majority, but they value passionate conviction when a partner pounds the table for a deal. The sustainability angle isn't just marketing fluff — they genuinely believe it drives long-term value creation. Their exit rate is 19 percentage points higher than average VCs, which suggests they know how to pick and support winners. With offices across the Nordics and strong ties to Silicon Valley, they're well-positioned to help ambitious founders scale globally.

Alven is a legitimate European powerhouse with 4 unicorns including Qonto (€4.4B valuation), Ankorstore, and Algolia - these aren't just marketing fluff, they're real fund-returners. The founding partners are old-school finance guys (Paribas, Lazard) who've been at this for 25 years - they know how to build companies and have seen multiple cycles. Their "straightforward honesty" philosophy isn't just PR speak - founders genuinely seem to appreciate their direct, no-BS approach and long-term commitment. The fund performance is genuinely impressive - potential €3B+ in portfolio value with multiple 10x+ returns already realized. However, they're very France-centric despite global ambitions, and their sweet spot seems to be established French entrepreneurs rather than first-time founders.

APEX Ventures is the rare European deep tech fund that actually understands what they're investing in - probably because their partners have real operational experience rather than just finance backgrounds. Andreas Riegler built and sold companies before becoming a VC, Wolfgang Neubert has deep technical expertise in photonics and quantum, and Gordon Euller is a practicing radiologist who worked at McKinsey. This translates into genuine value-add for founders wrestling with complex IP strategies and brutal commercialization timelines. The €80M Amadeus APEX Technology Fund partnership gives them serious firepower, and their portfolio companies consistently praise their hands-on support and network introductions. However, they're primarily focused on DACH region deals, so if you're not in Germany/Austria/Switzerland, you might be swimming upstream. Also, while they talk a good game about being 'founder-friendly,' deep tech investors by nature tend to want more control given the long development cycles and capital intensity.

Armilar is the real deal - they've backed three unicorns (OutSystems, Feedzai, Sword Health) and have genuine deep-tech credibility spanning 25+ years. Their track record of generating returns is grounded on backing founders throughout their journey, not just writing checks. However, they work on 16 percentage points less than the average amount of lead investments, meaning they're selective but might not always lead your round. The fact they successfully raised €120M in 2025's brutal fundraising environment speaks volumes about LP confidence in their returns. The senior team has been working together for a decade with 60+ years of cumulative VC experience - this isn't a new fund with untested dynamics.

Atlantic Bridge is the old guard of European tech - they've been doing cross-border deals since before it was cool. Brian Long and team have serious operator credentials (multiple IPOs, actual chip company exits) which matters when you're pitching deep tech. They're not just check-writers - they genuinely help European companies crack the US market through their Palo Alto office and connections. However, note that Atlantic Bridge gradually exited their entire position in Navitas stock in 2025 despite the company's strong showing that year - they know when to take profits. Their exit track record is legitimately impressive: Movidius to Intel, DecaWave to Qorvo, Blue Data to HPE, Hedvig to Commvault, NuVia to Qualcomm. They're particularly strong in semiconductors and enterprise software, but they move slowly and do serious due diligence.

Atlantic Labs is what happens when a successful serial founder (Christophe Maire) decides to back other founders with the same conviction he'd want for himself. Founders consistently say Atlantic is the only fund where you actually get support besides money you can count on - recruiting, strategy, operations. They move fast and aren't afraid of 'too early' or 'too bold' bets. The downside? One anonymous review claimed they were hands-off to the point where a portfolio founder ran wild across jurisdictions, hit a cash wall, and left employees unpaid - suggesting their conviction-based approach might sometimes lack operational oversight. But with 3 unicorns (Choco, GetYourGuide, Omio) in their portfolio, they clearly know how to pick winners.

Axon is that rare breed - a publicly traded VC (BME: APG) with €685 million AUM that actually knows what they're doing. With 1 unicorn (Forto), 7 IPOs, and 11 acquisitions in their portfolio, they've got the track record to back up the hype. The dual consulting-investment model is either genius or a distraction - it gives them deep sector insights but might split focus. Francisco Velazquez landing on the EU Innovation Council board shows they have serious Brussels connections, which matters for regulatory-heavy sectors. They're heavy on Spain/Southern Europe but expanding globally, so perfect if you're a Spanish startup needing local expertise and international ambitions. The climate tech push feels authentic given their track record, not just trend-chasing.

Bayern Kapital operates as a co-investor alongside private investors, adhering to the pari-passu principle, and typically holds minority stakes. We invest according to the pari-passu principle. In the case of a financing round, this means that all parties involved are treated equally and must invest the same amount of capital as Bayern Kapital. This is both their strength and potential limitation - they're patient, government-backed capital that won't push for quick exits, but they require private lead investors to move. With 3 unicorns (IQM, Quantum Systems, EGYM) and strong exits like MorphoSys, they clearly pick winners, but their bureaucratic structure means slower decisions than pure private funds. Their 8-10 year investment horizons and €700M+ AUM make them ideal for deep tech that needs patient capital, but expect more process and committees than your typical VC.

Big Pi is the real deal in the Greek/diaspora space - they're not just tourist money but serious operators with legit exits under their belt (Accusonus to Meta for €70-100M). The team brings actual entrepreneurial chops: Marco built Upstream to €230M revenue, Nick was at Prime Ventures doing serious European deals, and Alex literally helped create the Python data science stack. They require portfolio companies to maintain substantial Greek operations, which is both a feature (cheap talent, government support) and potential bug (geographic constraint). Their "tech-first" mandate with IP requirements means they actually understand what defensible tech looks like, unlike funds that chase flashy B2C plays.

Bright Pixel is basically Sonae's corporate venture arm with €250M deployed across 60+ companies, which sounds impressive until you realize they're essentially a retail conglomerate trying to stay relevant in tech. The good news: they have four unicorns including Feedzai and Arctic Wolf, proving they can spot winners. The reality check: as a corporate VC, they're always going to prioritize strategic value over pure financial returns, which means potential acqui-hire pressure down the road. Their team seems genuinely knowledgeable about cybersecurity and retail tech, but founders should expect longer decision cycles and more stakeholder management than with pure-play VCs.

BrightCap has already delivered 4-5 exits from their €25M Fund I, with portfolio companies raising $60M+ in follow-ons and reaching $600M+ enterprise value. Their biggest bet LucidLink has raised $115M total and could alone return their entire first fund. Fund II is one of the very few VCs with female majority among General Partners. They source 60% of deals through proprietary networks rather than waiting for inbound - they actively hunt. The 'global founders, local engineers' thesis is smart arbitrage: Western market access with Eastern European engineering talent costs. They're hands-on with diverse skill sets helping with product validation, talent recruitment, fundraising, and emotional support. But founders should know they need Bulgarian/Romanian engineering presence for public fund compliance.

This is Spain's establishment VC - they're the corporate venture arm of CriteriaCaixa, which manages over €25 billion and is backed by la Caixa Foundation. They've been around since 2007 and have made 300+ investments, so they know what they're doing, but they're also exactly what you'd expect from a big Spanish bank's VC arm. The good news: they have serious capital staying power, they actually stick around for follow-on rounds, and they exit 20% more often than average. The reality check: they're not exactly known for being the fastest movers or most founder-friendly when it comes to terms. New CEO Jordi Ros comes from 20 years of traditional corporate finance, not startup-land.

CIC has genuinely unique deal flow through their exclusive Cambridge University relationship - this isn't marketing fluff, they literally have privileged access to the best IP coming out of one of the world's top research universities. Their track record speaks for itself: Bicycle Therapeutics IPO on NASDAQ, CMR Surgical unicorn, Gyroscope sold to Novartis for $1.5B, plus solid exits like Inivata ($390M) and PetMedix ($285M). Williamson brings serious credibility - 20 years US VC experience and co-chaired the UK government's university spinout review, so he knows the ecosystem inside out. Their Entrepreneur in Residence program is actually working - they're co-founding companies like Immutrin (just raised £65M from Frazier Life Sciences) by pairing seasoned operators with Cambridge academics. The downside? You're essentially betting on Cambridge staying relevant in deep tech, and they're very UK-focused if you want Silicon Valley-style growth.

CDP is Italy's €4 billion sovereign wealth fund playing venture capitalist - which means you get the benefits of patient capital and government backing, but also all the bureaucracy that comes with it. They have an initial €1 billion to deploy and are making 40-50 investments per year, so they're not exactly selective. The real power here is Francesca Bria - she's the rare government appointee who actually gets technology and has street cred from transforming Barcelona's smart city approach. Under Resmini they grew from €230M to €4B AUM in 3 years, which is impressive scaling but raises questions about quality control. They're essentially the Italian government's attempt to bootstrap a venture ecosystem, so expect slower decision-making but also less pressure for quick exits since they're playing the long game for Italy's economic development.

Change Ventures is the real deal - probably the most founder-friendly fund in the Baltics with genuine operational chops. They ranked among Europe's top 10 VCs by founder reviews on Landscape, based on speed, responsiveness and value-add, which is rare for a regional fund. The partners aren't just check-writers; they've actually built and exited companies themselves. Andris has two $100M+ exits, the Ojasaar brothers literally created Estonia's VC ecosystem, and founders consistently praise their hands-on support: 'We've not only received full support, but Change Ventures provided the right hands-on at the right time, even unasked. Could not wish for better investors for the stage we're in.' They move fast, give clear feedback even when passing, and have a unicorn (Veriff) plus a solid exit (Nordigen to GoCardless) to show for it.

Fly is the anti-thesis fund that actually walks the walk. "If you are a deeply technical founder or working on a hard technical problem in Europe, your funding options at the inception stage mostly suck," stated Gabriel Matuschka. Founders often find it frustrating to simplify their pitches for investors who apply generic SaaS logic to everything. This approach can be harmful, especially in the early stages of deep tech development. These guys get in earlier than anyone else - Fly often engages with founders 6-9 months before they officially start their companies. The track record speaks for itself: Since Fly invested in Wayve's Seed Round in 2017, the company has raised a total in excess of USD 2B including its latest Series D at a USD 8.6B valuation and In September 2025, Check Point Software Technologies acquired Lakera for USD 300M. The catch? They're genuinely technical gatekeepers - Many early stage funds will say it's all about the team, but we like to think we keep a higher bar than most. If you can't geek out about your tech stack with Fredrik or convince Gabriel why your "impossible" problem is actually solvable, you're not getting in. But if you do make it through, Over 75 per cent of Fly's portfolio companies go on to raise a follow-on round or get acquired vs. the industry average of 31 per cent for Seed VCs in Europe.